In addition, high densities of activated TIL-Bs together with low densities of Tregs (FoxP3+/CD4+) in NSCLC tumors have consistently been associated with a better clinical outcome [67,68,69]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.